NCT00771056View on ClinicalTrials.gov

Hydroxychloroquine in Untreated B-CLL Patients

PHASE2TerminatedINTERVENTIONAL

Enrollment

23

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

B-Cell Chronic Lymphocytic Leukemia

Interventions

DRUG

Hydroxychloroquine

400mg by mouth daily x 1 year

Trial Locations (1)

11040

Long Island Jewish Medical Center CLL Research and Treatment Center, New Hyde Park

Sponsors

Lead Sponsor

Northwell Health

All Listed Sponsors

lead

Northwell Health

OTHER